Effectiveness of ciprofloxacin microspheres in eradicating bacterial biofilm

被引:12
作者
Owusu-Ababio, G [1 ]
Rogers, J
Anwar, H
机构
[1] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA
[2] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
基金
英国医学研究理事会;
关键词
ciprofloxacin; bacterial biofilm; sustained release; poly(L-lactic acid);
D O I
10.1016/S0168-3659(98)00113-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The treatment of cultures of planktonic cells and aged biofilm cells of P. aeruginosa and S, aureus with ciprofloxacin (CFX) microspheres of poly(L-lactic acid) (PLA) has been investigated using a modified, open in vitro chemostat system. The kinetics of release of CFX as a function of drug loading and the dose of microspheres were correlated with the rate and extent of killing and eradication of the planktonic cells and biofilm cells cultured on pieces of silicone tubing in the chemostat, respectively. At 71% w/w drug loading, a minimum dose of 7 mg of CFX in microspheres was required to sustain CFX concentration for about 10 h above the minimum inhibitory concentration (MIC) in order to completely eradicate the cells of either bacteria. In contrast, peak concentrations obtained from an equivalent dose of free CFX decreased to low values within 30 min and the bacteria cells were not eradicated. Lower microsphere loadings of CFX were ineffective at the same dose. Thus, this study has identified the formulation requirements for PLA microspheres to sustain CFX concentrations above the MIC for several days in order to eradicate bacteria, particularly aged biofilm cells, in the open chemostat in which the drug is being continually diluted, or similarly at a site of administration, for example, in the peritoneal cavity. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:151 / 159
页数:9
相关论文
共 32 条
[1]  
[Anonymous], AD PERIT DIAL
[2]   ENHANCED ACTIVITY OF COMBINATION OF TOBRAMYCIN AND PIPERACILLIN FOR ERADICATION OF SESSILE BIOFILM CELLS OF PSEUDOMONAS-AERUGINOSA [J].
ANWAR, H ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1666-1671
[3]   INTERACTION OF BIOFILM BACTERIA WITH ANTIBIOTICS IN A NOVEL INVITRO CHEMOSTAT SYSTEM [J].
ANWAR, H ;
VANBIESEN, T ;
DASGUPTA, M ;
LAM, K ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) :1824-1826
[4]   KINETIC INTERACTION OF BIOFILM CELLS OF STAPHYLOCOCCUS-AUREUS WITH CEPHALEXIN AND TOBRAMYCIN IN A CHEMOSTAT SYSTEM [J].
ANWAR, H ;
STRAP, JL ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :890-893
[5]  
ANWAR H, 1992, FEMS MICROBIOL LETT, V92, P235, DOI 10.1111/j.1574-6968.1992.tb05267.x
[6]   TESTING THE SUSCEPTIBILITY OF BACTERIA IN BIOFILMS TO ANTIBACTERIAL AGENTS [J].
ANWAR, H ;
DASGUPTA, MK ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2043-2046
[7]   ESTABLISHMENT OF AGING BIOFILMS - POSSIBLE MECHANISM OF BACTERIAL-RESISTANCE TO ANTIMICROBIAL THERAPY [J].
ANWAR, H ;
STRAP, JL ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1347-1351
[8]   THE INFLUENCE OF ENVIRONMENT ON ENVELOPE PROPERTIES AFFECTING SURVIVAL OF BACTERIA IN INFECTIONS [J].
BROWN, MRW ;
WILLIAMS, P .
ANNUAL REVIEW OF MICROBIOLOGY, 1985, 39 :527-556
[9]   CEFAZOLIN AND CEPHALEXIN KINETICS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
BUNKE, CM ;
ARONOFF, GR ;
BRIER, ME ;
SLOAN, RS ;
LUFT, FC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (01) :66-72
[10]   INVIVO DEGRADATION OF POLY(LACTIC ACID) OF DIFFERENT MOLECULAR-WEIGHTS [J].
CHAWLA, AS ;
CHANG, TMS .
BIOMATERIALS MEDICAL DEVICES AND ARTIFICIAL ORGANS, 1985, 13 (3-4) :153-162